Every 8-K that Hyperfine, Inc. (HYPR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow HYPR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HYPR filings page.
Hyperfine, Inc. (HYPR) disclosed that it received a Nasdaq notice on September 17, 2026 for not meeting the minimum bid price requirement for The Nasdaq Global Market. The company’s Class A common stock closed below $1.00 per share for 30 consecutive business days, triggering noncompliance with Nasdaq Listing Rule 5450(a)(1).
The notice does not immediately affect the listing or trading of the stock, and business operations and SEC reporting continue as before. Hyperfine has an initial 180-day compliance period until March 16, 2027, during which its closing bid must be at least $1.00 for a minimum of 10 consecutive business days to regain compliance.
If the company does not regain compliance by that date, it may seek an additional 180-day period by transferring its listing to The Nasdaq Capital Market and meeting that market’s listing standards other than the bid price, potentially including actions such as a reverse stock split. If compliance is still not achieved, the stock may be delisted, subject to a possible appeal to a Nasdaq Hearings Panel.
Hyperfine, Inc. reported higher revenue and system placements for the second quarter ended June 30, 2026. Revenue was $3.9 million, up 44.8% from $2.7 million a year earlier, alongside 12 commercial Swoop® systems sold versus 8 in 2025. Gross profit rose to $2.0 million with a 50.7% gross margin. Operating expenses totaled $10.4 million, with lower research and development spending, and the company recorded a net loss of $9.3 million, or $0.09 per share, similar to the prior year.
Cash and cash equivalents were $43.5 million as of June 30, 2026, up from $35.1 million at year-end, primarily reflecting financing activities completed during the first half of 2026. Management continues to expect 2026 revenue of approximately $20–$22 million and cash burn of approximately $26–$28 million. Hyperfine also reported CE Mark and UKCA approvals and the European launch of its next-generation Swoop® portable MRI system, plus record U.S. scan volumes.
Hyperfine, Inc. reported the results of its 2026 annual stockholder meeting. Holders of 44,587,577 Class A shares and 15,055,288 Class B shares were present in person or by proxy, representing approximately 89.89% of the voting power, which constituted a quorum. Stockholders had one vote per Class A share and 20 votes per Class B share as of the March 25, 2026 record date.
All five nominated directors—Daniel J. Wolterman, Maria Sainz, John Dahldorf, Ruth Fattori, and Jonathan M. Rothberg, Ph.D.—were reelected to serve until the 2027 annual meeting, each receiving over 314 million votes in favor and around 1 million or fewer votes against, with broker non-votes of 29,991,466 for each nominee. Stockholders also ratified the appointment of Grant Thornton LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 341,824,976 votes for, 3,658,781 against, and 209,580 abstentions.
Hyperfine, Inc. reported strong first quarter 2026 growth while remaining unprofitable. Revenue reached $3.90 million, up 83% from $2.14 million a year earlier, driven by sales of 10 Swoop® systems versus six in the prior-year quarter. Gross profit rose to $1.98 million, and gross margin improved to 51% from 41%.
Operating expenses declined slightly, with research and development down to $3.85 million from $5.04 million. Net loss narrowed to $8.62 million, or $0.09 per share, from $9.42 million, or $0.12 per share. Cash, cash equivalents and restricted cash increased to $41.28 million, supported by a $15.0 million debt financing that extends the expected cash runway into 2028. Management reaffirmed 2026 guidance for revenue of about $20–$22 million and cash burn of $26–$28 million.
Hyperfine, Inc. entered into a senior secured term loan agreement with Horizon Technology Finance for up to $40.0 million. The company drew $15.0 million at closing, with another $25.0 million available through December 31, 2027 if conditions are met.
The loan bears interest at the prime rate plus 4.25%, with a prime floor of 6.50% and a minimum overall rate of 10.75%, and initially requires 48 months of interest-only payments. Hyperfine paid a $400,000 commitment fee and must make a final payment equal to 5.0% of the aggregate original principal at payoff.
As part of the financing, Hyperfine issued warrants to Horizon for up to 562,500 shares of Class A common stock as Initial Warrants and up to 520,835 shares as Additional Warrants, each with a $1.20 exercise price. The Initial Warrants are immediately exercisable, while the Additional Warrants become exercisable only if further loan tranches are funded. The loan is guaranteed by two wholly owned subsidiaries and secured by substantially all company assets, subject to customary exclusions, and includes standard covenants and events of default.
Hyperfine, Inc. reported strong top-line momentum for the fourth quarter and full year 2025 while continuing to operate at a net loss. Fourth quarter 2025 revenue was $5.29 million, up 128% from $2.32 million a year earlier, with net 16 Swoop® systems sold versus nine in the prior-year quarter. Gross margin improved to 51% from 36%, and the quarterly net loss narrowed to $5.91 million, or $0.06 per share, compared with a $10.39 million loss, or $0.14 per share.
For full year 2025, revenue reached $13.56 million, up 5.2% from 2024, on 38 systems sold versus 48 in 2024, while gross margin rose to 50% from 46%. The annual net loss was $35.57 million, or $0.43 per share, better than the $40.72 million loss, or $0.56 per share, in 2024. Cash and cash equivalents were $35.09 million as of December 31, 2025, and the company highlighted over $20 million in gross proceeds from an October 2025 equity offering and a $40 million senior secured term loan facility signed in March 2026.
Management guided 2026 revenue to approximately $20 to $22 million, implying 55% growth at the midpoint versus 2025, and expects 2026 cash burn of $26 to $28 million, a 10% decline at the midpoint. The company expects its recent financings and initial debt tranche to support a cash runway into 2028 as it drives adoption of its second-generation Swoop® scanner and Optive AI™ software across hospital, neurology office and international markets.
Hyperfine, Inc. reported preliminary, unaudited financial results for the quarter and year ended December 31, 2025. The company estimates total revenue of approximately $5.3 million for the fourth quarter of 2025 and approximately $13.5 million for the full fiscal year 2025, with estimated cash and cash equivalents of about $35.1 million as of December 31, 2025. These figures are based on management’s current information, may change as year-end financial statements are completed, and have not been audited or reviewed by the independent registered public accounting firm. Hyperfine also furnished a press release and an updated investor presentation dated January 12, 2026, which it may use in ongoing investor and corporate communications.
Hyperfine, Inc. furnished an 8-K announcing its third-quarter 2025 results. The company reported results for the quarter ended September 30, 2025 and provided a business update via a press release furnished as Exhibit 99.1 under Item 2.02.
The filing lists Hyperfine’s Class A common stock (HYPR) on The Nasdaq Stock Market LLC. The press release is furnished, not filed, and is incorporated only by specific reference.
Hyperfine, Inc. priced an underwritten public offering of 14,000,000 shares of Class A common stock at $1.25 per share, for expected gross proceeds of approximately $17.5 million before fees and expenses. The underwriter, Lake Street Capital Markets, LLC, has a 30-day option to purchase up to 2,100,000 additional shares. All shares are being sold by the company, and the offering is being made via a prospectus supplement under the company’s effective Form S-3 shelf registration.
The offering is expected to close on or about October 17, 2025, subject to customary conditions. Underwriting discounts are 7.0% on the first $10 million of gross proceeds and 6.0% on any amount above that, and the company will reimburse certain underwriter expenses up to $125,000. The company agreed to a 90-day no-issuance covenant, and directors and executive officers agreed to 60-day lock-ups.
Hyperfine (HYPR) furnished preliminary, unaudited Q3 2025 results. For the quarter ended September 30, 2025, the company estimated total revenue of approximately $3.4 million. Cash and cash equivalents were approximately $21.6 million as of September 30, 2025.
Management emphasized these figures are preliminary, subject to change, and have not been audited, reviewed, or compiled by the independent registered public accounting firm. Complete quarterly results will be included in the Quarterly Report on Form 10‑Q for the quarter ended September 30, 2025.
The company also issued a press release and updated its Investor Presentation, furnished as Exhibits 99.1 and 99.2. The information was furnished, not filed, under the Exchange Act.
Hyperfine, Inc. furnished a press release announcing results for the second quarter ended June 30, 2025 and provided a business update; the press release is attached as Exhibit 99.1 to this Form 8-K.
The filing states the furnished material is not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference. The company lists its Class A common stock (HYPR) on The Nasdaq Stock Market and indicates it is an emerging growth company. The report is signed by Brett Hale in his capacities as Chief Administrative Officer and Chief Financial Officer.
Hyperfine, Inc. (HYPR) received a Nasdaq notice on April 30, 2025 that its closing bid price fell below the $1.00 minimum for 30 consecutive business days and therefore did not meet Nasdaq Listing Rule 5450(a)(1). On August 6, 2025, Nasdaq notified the Company that it has regained compliance with the bid-price requirement and the matter is closed.
Key facts:
- Nasdaq deficiency notice: April 30, 2025
- Regained compliance and matter closed: August 6, 2025
- Ticker: HYPR; security: Class A common stock on the Nasdaq Global Market